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AbstrAct
Objectives The aim of this study was to examine the impact 
of transient ischaemic attack (TIA) service modification in two 
hospitals on costs and clinical outcomes.
Design Discrete event simulation model using data from 
routine electronic health records from 2011.
Participants Patients with suspected TIA were followed 
from symptom onset to presentation, referral to specialist 
clinics, treatment and subsequent stroke.
Interventions Included existing versus previous (less 
same day clinics) and hypothetical service reconfiguration 
(7-day service with less availability of clinics per day).
Outcome measures The primary outcome of the model 
was the prevalence of major stroke after TIA. Secondary 
outcomes included service costs (including those of 
treating subsequent stroke) and time to treatment and 
attainment of national targets for service provision 
(proportion of high-risk patients (according to ABCD2 
score) seen within 24 hours).
results The estimated costs of previous service provision for 
490 patients (aged 74±12 years, 48.9% female and 23.6% 
high risk) per year at each site were £340 000 and £368 000, 
respectively. This resulted in 31% of high-risk patients seen 
within 24 hours of referral (47/150) with a median time from 
referral to clinic attendance/treatment of 1.15 days  
(IQR 0.93–2.88). The costs associated with the existing and 
hypothetical services decreased by £5000 at one site and 
increased £21 000 at the other site. Target attainment was 
improved to 79% (118/150). However, the median time 
to clinic attendance was only reduced to 0.85 days (IQR 
0.17–0.99) and thus no appreciable impact on the modelled 
incidence of major stroke was observed (10.7 per year, 99% CI 
10.5 to 10.9 (previous service) vs 10.6 per year, 99% CI 10.4 
to 10.8 (existing service)).
conclusions Reconfiguration of services for TIA is effective 
at increasing target attainment, but in services which are 
already working efficiently (treating patients within 1–2 
days), it has little estimated impact on clinical outcomes and 
increased investment may not be worthwhile.
bAckgrOunD
Transient ischaemic attack (TIA) is common, 
with incidences of 15–83 patients per 100 000 
population recorded across the world1–5; in 
the UK, it affects approximately 50 patients 
per 100 000 population.6 TIA is important 
because it represents a significant risk factor 
for future stroke with around 8% suffering an 
event within 7 days, and 12% within a month 
without preventative therapy.7 8 
Rapid recognition and treatment of 
TIA patients at high risk of having a subse-
quent stroke is important because simple 
interventions, such as early prescription of 
preventative medications, can substantially 
reduce the risk of stroke following TIA, and 
existing evidence suggests that earlier inter-
vention may be better.9 10 In the UK, guide-
lines11 12 recommend that patients at high 
risk of recurrent stroke (defined using the 
ABCD2 score of >4)10 are seen within 24 hours 
of symptom onset and all other patients are 
seen within 7 days. A recent UK audit suggests 
that there has been significant improvement 
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Research
strengths and limitations of this study
 ► This study focused on two hospitals within the 
West Midlands, UK, so the results are likely to be 
representative of these hospitals, but not necessarily 
other centres in the UK and across the world.
 ► Modelling allows estimation of service ‘unknowns’ 
which requires preprogramming and therefore 
simplification of certain service intricacies. Thus, the 
services modelled represent stylised versions of the 
actual services offered by participating hospitals.
 ► Costs relate to standard weekday services and it is 
not clear whether those actually incurred would be 
increased by provision of services at the weekend.
 ► The potential costs of implementation of new 
services, for example those for weekend services, 
were unavailable and so the costs presented here 
may have been underestimated.
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Table 1 Patient characteristics as modelled
Patient characteristics
Age (mean±SD) (years) 74±12
Gender (female, %) 240 (48.9)
Systolic blood pressure (mean±SD) (mm Hg)
TIA mimic 143±26
  TIA 147±22
  Minor stroke 144±18
  Overall mean 145±24
Final diagnosis (Actual condition)
  High-risk TIA 116 (23.6%)
  Low risk TIA 46 (9.4%)
  TIA mimic 294 (60.0%)
  Minor stroke 34 (7.0%)
Patients referral to hospital via their GP according to 
diagnosis*
  High-risk TIA 84 (72.3%)
  Low-risk TIA/TIA mimic 299 (87.9%)
  Minor stroke 20 (57.4%)
  Overall mean 402 (82.1%)
*Expected numbers are rounded to the nearest integer, the 
apparent anomaly with the addition results from this rounding. 
High-risk patients defined as an ABCD2 score of >4.
GP, general practitioner; TIA, transient ischaemic attack.
in attainment of these targets: 45% of high-risk outpa-
tients and 60% of inpatients now receive treatment on 
the same day as referral, compared with just 10% and 
33% 4 years earlier.13 This improved target attainment has 
been achieved through a variety of approaches, with some 
centres admitting more patients for assessment and treat-
ment and others designing services with excess routine 
clinic capacity.14
Service reconfiguration remains ongoing in routine 
clinical practice, and it is unclear what impact such 
changes have on service costs and clinical outcomes. 
This study used discrete event simulation modelling 
to assess the impact of TIA service reconfiguration in 
two large urban hospitals with different approaches to 
service provision.
MethODs
An extended methods section can be found in the online 
supplementary data.
setting and service design
The model was designed to assess the costs and clinical 
consequences arising from patients suspected of suffering 
an acute TIA, referred to two large urban hospitals in 
the West Midlands region of the UK. Both hospitals ran a 
specialist TIA outpatient service catering for approximately 
500 patients with suspected TIA and minor stroke every 
year. The model parameters were defined by the character-
istics of individuals attending these services, recruited to an 
observational study15 during 2011 (table 1).
The availability of specialist TIA clinics was modelled 
on the basis of existing service provision at partici-
pating hospital sites during the study period. Patients 
could either be seen in traditional outpatient clinics, 
admitted, or seen on the ward on an outpatient basis. 
The original services were designed within the confines 
of available clinical staff and in particular a lack of 
specialist cover at the weekends. Services were rede-
signed at each site during the study period and the 
impact of these changes on cost and outcomes was 
examined by modelling both the original and modified 
service. The number and distribution of clinics in each 
service are described in table 2.
The impact of further hypothetical adjustments to the 
modified service at each site was modelled to replicate 
the following scenarios:
1. The addition of high-risk clinic slots for patients 
presenting on a Saturday and Sunday.
2. Including a weekend service but reducing the number 
of routine weekday clinics, by up to five clinic slots 
(one patient per slot) per week.
Overview of the model
A discrete event simulation model was programmed in 
Delphi V.4 (Borland, San Francisco, CA, USA). It was 
adapted from a previously developed model and further 
details regarding the general modelling framework can 
be found in the original report.16 Briefly, the model 
generated a number of possible (virtual) patient histo-
ries, which began at the onset of TIA (or TIA-like) symp-
toms, and followed the patient along the clinical pathway 
from initial presentation to follow-up for subsequent 
stroke morbidity and mortality. An essential feature of the 
model was that patients were sharing limited resources in 
the form of routine clinics.
clinical pathways in the model
Following onset of an initial event, patients were 
assumed to contact either their general practitioner 
(GP) or attend the emergency department (ED) 
(online supplementary figure). The probability that a 
patient would choose a specific route was dependent 
on the type of patient (high/low risk), the time of day 
and day of week, estimated using data from the Oxford 
Vascular Study.17 Following this initial contact with 
a healthcare professional, patients were referred to a 
specialist TIA outpatient clinic, seen on the ward (as 
an outpatient) or admitted as an inpatient. The type of 
referral was dependant on the specific hospital service 
provision, clinic availability and the level of risk of 
attending the patient, defined according to the ABCD2 
score.10 During clinic attendance, it was assumed that 
the appropriate treatment would be initiated (ie, 
blood pressure lowering, cholesterol lowering or anti-
platelet therapy in accordance with guidelines) and a 
small proportion of patients (4.1%) would be treated 
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Table 2 Pattern of outpatient clinics for suspected transient ischaemic attack based on actual service provision at 
participating hospitals during patient recruitment period
Hospital and 
service
No of routine clinic slots 
available by day of the week
Total 
clinics  
per year Details of clinic allocation within the modelMon Tues Wed Thur Fri
Hospital 
1
Original 
service*
2 4 4 4 2 724 All patients are assigned to the next available clinic slots 
in order of referral. Where two referrals are made in 1 day, 
high-risk patients are given priority.
Modified 
service*
4 4 2 3 4 769 Where two referrals are made in 1 day, high-risk patients 
are given priority. One slot is reserved at the end of each 
clinic for high-risk referrals. If the next high-risk clinic 
slot is not within 24 hours of referral, an additional slot 
is made available (up to one per day). All other patients 
are assigned to the next available clinic slots in order of 
referral.
Hospital 
2
Original 
service†
6 4 2 0 0 624 Patients are assigned to the next available outpatient 
clinic. Those high-risk patients who cannot be seen within 
24 hours are admitted (including those presenting at 
weekends).
Modified 
service†
4 or 6‡ 0 4 0 4 676 All high-risk patients are seen on the ward as outpatients 
as required (including at weekends). Patients referred 
before 10:00 are seen at 17:00 on the same day, patients 
referred after 10:00 are seen at 10:00 on the following day. 
All low-risk patients seen at the next available clinic in 
order of referral.
*Clinics are divided among four specialists, each of whom were absent for approximately 7 weeks a year (annual leave). These clinics are 
assumed not to take place if the specialist is absent.
†Specialists were absent for approximately 7 weeks a year (annual leave). All absent clinicians were replaced by a specialist from another site 
within the Trust.
‡There is a 50% probability each week that either four or six clinic slots will be available.
with carotid endarterectomy.12 18 Patients were assumed 
to take this treatment as prescribed and gain the full 
benefit in terms of stroke prevention.
Model population
All patients in the model were hypothetical, although they 
were based on data from real patients and hospitals. Overall 
rates of patient presentation were based on initial runs of 
the model and ensured a realistic distribution of final diag-
noses, which represented the study sample, previous litera-
ture14 and expert opinion (60% TIA mimics, 33% genuine 
TIA and 7% minor stroke). High-risk and low-risk TIAs were 
defined according to the ABCD2 score.10 The observed ratio 
of low-risk/high-risk TIA patients used in the base-case of the 
model was supplemented in sensitivity analyses by estimates 
derived from those reported in previous studies10 19 20 and 
the experience of stroke physicians from centres across the 
UK (D Sims, G Ford and C Roffe, personal communication). 
The range of these estimates tested in this sensitivity anal-
ysis for impact on the model results was: 2.5:1 (high:low risk; 
base-case) to 1:1, 5:1 and 7:1.10 19 20
Follow-up and risk of repeat events
Hypothetical patients remained in the model until 
1 year from symptom onset, after which the increased 
risk of repeat event returns close to normal,7 8 unless 
they died or suffered a non-fatal disabling stroke. No 
distinction was made in the model between fatal strokes 
and non-fatal disabling strokes: these were labelled 
as ‘major strokes’. The risk of a repeat event (TIA 
or stroke) was dependent on the type of initial event 
(minor stroke, true TIA or mimic), the ABCD2-based 
risk prediction of a subsequent event and other relevant 
risk factors, such as age, presence of atrial fibrillation 
and medication prescribed.10 18 21–26 Following a minor 
(non-disabling) stroke, patients remained in the model, 
but with an additional risk of mortality that could be 
reduced by appropriate treatment. Additional deaths 
from this cause were estimated and labelled in the model 
outputs as ‘post-stroke deaths’. Modelled outputs are, 
therefore, derived from risk profile of the hypothetical 
patients, adjusting for the effects of treatments which 
would start at varying times in the different scenarios. 
Risks were modelled using a Weibull distribution for the 
time to event which allowed for a substantially increased 
risk in the short term, followed by a decreasing risk over 
time.9 Examples of the modelled risk for two patients 
(with high-risk and low-risk characteristics) are given in 
figure 1. The model was run 100 times for a total simu-
lated time of 12 years in each run.
costs and outcomes
The model included costs of any GP visit (from presenta-
tion to referral), or transport by ambulance to the ED and 
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Figure 1 Example survival curves and daily hazard rates for the risk of major stroke in high-risk and low-risk patients. High-
risk patient: male age 70–74 years, SBP 156 mm Hg, speech disturbance without weakness, duration of symptoms 60+ min, 
not diabetic (resulting in ABCD and ABCD2 scores of 5), undiagnosed Atrial fibrillation (AF), cholesterol 5.8. Low-risk patient: 
male age 70–74 years, SBP 115 mm Hg, speech disturbance without weakness, duration of symptoms 0–9 min, not diabetic 
(resulting in ABCD and ABCD2 scores of 2), AF on warfarin, cholesterol 6.0.
ED attendance, outpatient clinics or hospital admission 
for TIA and stroke, surgery and therapy (online supple-
mentary tables 1 and 2). Prehospital and treatment- 
related costs were the same for all options considered in 
this study since the focus was to compare comparative 
differences between modelled services caused by different 
clinic configurations. Costs included in the model were 
taken from a combination of NHS reference costs27 28 
and drug costs from the British National Formulary29 and 
were modelled from a health services perspective. The 
price year for all costs was 2011–2012.
The primary outcome was the number of expected 
major strokes occurring post TIA, based on risk anal-
ysis. Secondary outcomes included the overall costs of 
service provision per year and attainment of national 
targets for TIA service provision. Target attainment 
was defined as the number of high-risk and low-risk 
‘breaches’, which occurred in each service per year: 
high-risk breaches were defined as a high-risk patient not 
seen by a specialist within 24 hours of initial referral.11 12 
Low-risk breaches were defined as low-risk patients not 
seen by a specialist within 7 days of referral.11 12 Further 
outcomes examined the median time from referral to 
specialist appointment, the total number of routine 
outpatient appointments available (used or unused) 
and any unscheduled outpatient appointments required 
(where high-risk patients were assessed immediately on 
the ward).
All data are presented as means or medians±SD, IQR or 
99% CI, chosen because multiple values are compared. 
Percentages are given for the total population unless 
otherwise stated.
results
tIA service usage
The model estimated a total of 490 patients would 
be referred to specialist TIA clinics each year at each 
hospital site (mean age 74±12 years; 48.9% female 
(table 1)). Of these, approximately 34 (7%) patients 
would be considered to have minor stroke and 162 
(33%) would subsequently be considered to have 
confirmed TIA: the numbers classified as high/low risk, 
were 116/46, a ratio of 2.5:1. All subsequent results 
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Table 3 Costs, resource utilisation and outcomes (per year) of modifying TIA service provision in hospital 1
Original service 
(16 clinic slots per 
week)
Modified service 
(17 clinic slots per 
week)
Weekend 
service+17 clinic 
slots per week)
Weekend 
service+15 clinic 
slots per week)
Weekend 
service+13 clinic 
slots per week)
Days operating per 
week
5 5 7 7 7
Total no of patients 
presenting
491 490 490 491 491
Cost of clinics used and 
unused
£340 000 £361 000 £366 000 £346 000 £325 000
Major strokes post TIA 
(mean, 99% CI)*
10.6 (10.4 to 10.8) 10.7 (10.5 to 10.9) 10.6 (10.4 to 10.8) 10.8 (10.6 to 11.0) 10.6 (10.4 to 10.8)
Poststroke deaths 
(mean, 99% CI)*
3.0 (2.9 to 3.1) 3.0 (2.9 to 3.1) 3.0 (2.9 to 3.1) 3.1 (3.0 to 3.2) 3.0 (2.9 to 3.1)
No of high-risk 
breaches (%)†
103 (69) 32 (21%) 6 (4%) 7 (5%) 8 (5%)
No of low-risk breaches 
(%)‡
7 (2) 4 (1%) 3 (1%) 13 (4%) 75 (22%)
Time from referral to 
clinic appointment for 
high-risk patients in 
days, median (IQR)
1.15 (0.93–2.88) 0.85 (0.17–0.99) 0.68 (0.16–0.93) 0.70 (0.15–0.93) 0.86 (0.16–0.99)
*Point estimate and 99% quasi CI reflecting the uncertainty from sampling in the model, not any uncertainty in model parameters. 99% was 
chosen because of multiple values were compared.
†High-risk breaches were defined as high-risk patients not seen by a specialist within 24 hours of initial clinic referral.12
‡Low-risk breaches were defined as low-risk patients not seen by a specialist within 7 days of initial clinic referral.
Of the ~490 patients in the model, 340 are considered low risk (294 TIA mimic; 46 low-risk TIA) and 150 are considered high risk (116 high-
risk TIA; 34 minor stroke).
TIA, transient ischaemic attack.
were robust to adjustment of this high-risk:low-risk ratio 
in the sensitivity analyses.
costs and outcomes of original tIA service provision
The baseline incidence of major strokes post TIA was 
10.6 per year (99% CI 10.4 to 10.8) in hospital 1 and 
10.7 per year (99% CI 10.5 to 10.9) in hospital 2. The 
cost of providing TIA services at both sites ranged from 
£340 000 to £368 000 per year (table 3 and online 
supplementary table 3). Services included the provision 
of 624–724 specialist week day clinic slots per year. In 
hospital 1, few high-risk patients were seen within 24 hours 
of referral (47/150 patients (31%)) and the median time 
from referral to clinic appointment was 1.15 days (IQR 
0.93–2.88). In hospital 2, where all high-risk TIAs were 
admitted (a target attainment of 100%), the median time 
from referral to being seen and treated by a specialist was 
0.85 days (IQR 0.74–0.94).
Impact of service modification
Observed service modification increased the number 
of high-risk patients seen within 24 hours in hospital 
1 (118/150; guideline target attainment of 79%), with 
increased service costs (increased from £3 44 000 to 
£3 66 000 per year) due to an increase in the number of 
unused routine clinic appointments (225–316 unused 
clinic slots per year) (figure 2). This increase in target 
attainment resulted in a median time from referral to 
clinic appointment of 0.85 days (IQR 0.17–0.99); the 
incidence of major strokes post TIA remained largely 
unchanged (10.6 per year, 99% CI 10.4 to 10.8 (modi-
fied service) vs 10.7 per year, 99% CI 10.5 to 10.9 
(original service)). Similar findings were observed at 
the second hospital site where costs were marginally 
reduced by not admitting patients with high-risk TIA 
(decrease from £3 68 000 to £3 63 000 per year) but 
there was no change in the number of patients being 
seen within 24 hours (150/150; guideline target attain-
ment of 100%), median time from referral to clinic 
appointment (0.75 days, IQR 0.08–0.88 (modified 
service) vs 0.85 days, IQR 0.17–0.99 (original service)) 
or incidence of major strokes post TIA (10.4 per year, 
99% CI 10.2 to 10.4 (modified service) vs 10.7 per year, 
99% CI 10.5 to 10.9 (original service)).
Potential optimal service provision
Modelling the impact of further hypothetical service recon-
figuration, including a 7-day service, suggested that it was 
possible to reduce service costs and the number of unused 
clinic appointments and improve guideline target attain-
ment, but this had little impact on the incidence of major 
stroke post TIA or poststroke deaths (table 3 and online 
supplementary table 3). Figure 2 shows the trade-off between 
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Figure 2 Outcomes of service provision in terms of clinic 
appointment utilisation and guideline breaches. Original 
and modified services (first two bars at each hospital) were 
those which were actually implemented in each hospital. The 
remaining weekend services are hypothetical. *Hospital 1 
included 16 routine clinics, 5 days per week (original service), 
17 in the modified service and 19 in the modified service with 
weekend working. †Hospital 2 included 12 routine clinics, 
3 days per week (original service) and 14 in the modified 
service (which also included weekend working). HR, high risk; 
LR, low risk; OP, outpatient appointment;   
TIA, transient ischaemic attack.
routine appointment provision, unscheduled appointments 
and high/low-risk guideline breaches. Assuming unused 
appointments (pink), unscheduled appointments (in light 
blue), admissions (purple) and breaches (red (high-risk 
breaches) and light red (low-risk breaches)) are preferably 
avoidable outcomes of service provision, the optimal hypo-
thetical service in hospital 1 involved a weekend service 
with approximately 17–18 routine clinic appointments per 
week. In hospital 2, where more unscheduled appointments 
were incurred, the optimal hypothetical service involved a 
weekend service with 10–11 routine clinic slots distributed 
across the week on Mondays, Wednesdays and Fridays (with 
high-risk patients being seen in unscheduled appointments 
on the ward on any day of the week if necessary).
DIscussIOn
The aim of this study was to model the impact of TIA 
service reconfiguration in two large urban hospitals 
and establish the impact on clinical outcomes (major 
strokes), costs and clinic usage. Reconfiguration of 
services was found to be effective and appropriate for 
reducing resource (clinic slot) waste, and improving 
guideline target attainment with variable effects on 
costs. However, in hospitals where services, despite 
poor target attainment, had minimal patient delays, 
such as those studied here, significant reconfigura-
tion had little impact on modelled clinical outcomes 
such as major stroke post TIA. These findings suggest 
that clinicians and service coordinators should be 
cautious before initiating significant reconfiguration 
of services which are already seeing high-risk patients 
within 1–2 days, unless there is an obvious need to free 
up resources which could be used for another purpose 
(eg, managing other types of patients). While national 
targets for care are important, consideration should 
be given to revising them to maximise the benefits 
of attainment while not incentivising small changes 
that might increase costs for no measurable clinical 
benefit.
strengths and limitations
This study used local hospital data to describe the charac-
teristics of the presenting population and thus the results 
are likely to be representative of the hospitals studied, but 
not necessarily generalisable to other centres in the UK 
and across the world. Despite this, guideline target attain-
ment in hospital 1 (original service configuration) was 
similar to that reported nationally (31% vs 37% nation-
ally),13 which suggests that this hospital was more likely 
representative of centres across the UK.
Modelling allows estimation of service ‘unknowns’, 
such as the number of unscheduled clinic appoint-
ments required to meet guideline targets for high-risk 
patients. This requires preprogramming with hypothet-
ical patients and specific rules; therefore, simplification 
of certain service intricacies is necessary. For example, 
the process by which high-risk patients were allocated 
unscheduled clinic appointments was formalised such 
that a patient referred by the ED physician was assumed 
to have been seen by a stroke specialist within 2 hours. 
However, patients referred by their GP were assumed to 
be seen by the stroke specialist on the ward at 10:00 the 
following morning or 17:00 the same day, whichever was 
later (but within 24 hours of initial referral). In reality, 
services are often adapted in response to a specific set of 
circumstances such as clinic room availability and thus 
the services modelled here, and the patients attending 
these services, can best be thought of as stylised versions 
of the actual services available and patients attending the 
hospitals in question.
The risk of recurrent stroke attributed to hypothet-
ical patients in the model was based on an estimated 
ABCD2 score.10 The accuracy of this score for predicting 
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recurrent stroke has been called into question with a 
recent systematic review showing it to have poor discrim-
ination between those at low risk and high risk of early 
(7 days) stroke.30 However, this was the score used and 
recommended in practice at the time these services 
were modelled and was used for all service configura-
tions examined, so our relative comparisons are likely 
to remain valid, even if the absolute numbers may be 
subject to change.
The costs modelled here were taken from standard 
NHS reference costs27 28 and included investigations, 
treatment and the cost of staff attending patients 
during each appointment/admission. Costs relate 
to standard weekday services and increased rates for 
weekend services were unavailable for this analysis. 
It is, therefore, likely that the costs of providing a 
weekend service may have been underestimated in the 
present analyses.
Findings in the context of previous literature and implications 
for practice
Economic modelling has previously been used for deter-
mining the impact of service reconfiguration in acute 
stroke31–34 but studies examining optimal strategies 
for TIA service provision are less common. Those that 
exist, focus on whether patients should be admitted or 
be seen as an outpatient.16 35 36 It is generally accepted 
that patient admission for TIA is inefficient and not 
cost-effective,16 37–39 but there are a paucity of objective data 
comparing different configurations of outpatient service 
in the same setting, limited to questionnaire surveys of 
stroke physicians14 40 and the Sentinel Stroke National 
Audit Programme (SSNAP) in the UK.13 A recent review 
identified six models of care designed to avoid patient 
admission for TIA. These ranged from patient assess-
ment and triage in the ED, a 24 hour nurse-led telephone 
advice service and the primary care triage system studied 
here (+/−electronic decision support).41 The appropriate 
model of care will depend on the local healthcare system, 
but consideration of how such a model is implemented in 
terms of service configuration is warranted, regardless of 
the system used.
The primary finding of this study was that while service 
reconfiguration can significantly improve guideline 
target attainment and potentially reduce service costs, 
such changes have little impact on the estimated prev-
alence of subsequent stroke, when services are already 
working efficiently. In this study, even the largest service 
reconfiguration (introduction of a 7-day service) only 
reduced the median time from patient referral to clinic 
attendance and treatment by 0.3 days (8 hours). This 
enabled a large number of patients to be seen within 
24 hours, improving guideline target attainment but 
had little impact on stroke risk. The recommendations 
for a ‘see and treat within 24 hours’ target for high-risk 
patients were originally based on data from the EXPRESS 
study,9 which showed that those patients seen and treated 
within 24 hours of initial referral had significantly better 
outcomes than those patients who were not. However, 
in the original service to which this optimal strategy 
was compared, the average time from referral to clinic 
appointment was 3 days (IQR 2–5 days) and time to first 
treatment was 20 days (IQR 8–53). The improvement 
in time to initiation of treatment was therefore 20 days, 
compared with an improvement of 8 hours seen in this 
study, which explains the very different results in terms of 
clinical outcome.
Recent results from SSNAP show that 45% of high-
risk outpatients and 60% of high-risk inpatients are 
seen and treated within 24 hours of referral, suggesting 
that there is plenty of room for improvement. However, 
with a median time to first clinic appointment (and 
treatment) for all patients of just 2 days, the present 
analyses would suggest that further improvements in 
guideline target attainment may have little impact on 
major stroke following TIA.
The modified services examined and proposed here may 
require the capacity to accommodate unscheduled clinic 
appointments, which is likely to have an opportunity cost 
affecting the quality of other services running concurrently 
in the hospital and may result in increased costs with little 
tangible benefit. In particular, the ability to accommodate 
such appointments depends on the time of day at which the 
patient presents, the availability of specialist stroke physi-
cians and scanning equipment required to make an accurate 
diagnosis, as well as the needs of competing services within 
the hospital (eg, acute stroke services).
cOnclusIOns
Reconfiguration of specialist services for TIA can be 
effective and appropriate for reducing costs, reducing 
the number of unused routine clinic appointments 
and increasing clinical guideline target attainment. 
However, where services are already working near 
optimal, such modification has little impact on clin-
ical outcomes such as subsequent stroke. Clinicians 
and service coordinators should be cautious before 
initiating significant reconfiguration of services which 
are already seeing high-risk patients within 1–2 days, 
although this might still be appropriate if resources 
within the hospital are freed up and could be used for 
an alternate purpose.
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